This page is part of the FHIR Specification (v4.3.0: R4B - STU). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B
Biomedical Research and Regulation Work Group | Maturity Level: N/A | Standards Status: Informative | Compartments: Not linked to any defined compartments |
Raw JSON (canonical form + also see JSON Format Specification)
Example of clinicalusedefinition
{ "resourceType": "ClinicalUseDefinition", "id": "example", "text": { "status": "generated", "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\">Resource "example" </p></div><p><b>type</b>: contraindication</p><blockquote><p><b>contraindication</b></p></blockquote></div>" }, "type": "contraindication", "contraindication": { "diseaseSymptomProcedure": { "concept": { "coding": [ { "system": "http://ema.europa.eu/example/contraindicationsasdisease-symptom-procedure", "code": "Coagulopathiesandbleedingdiatheses(exclthrombocytopenic)" } ], "text": "Hepatic disease associated with coagulopathy and clinically relevant bleeding risk" } }, "comorbidity": [ { "concept": { "coding": [ { "system": "http://ema.europa.eu/example/comorbidity", "code": "Hepaticdisease" } ] } } ] } }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.